Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?

被引:5
|
作者
Nakada, K
Ishibashi, T
Takei, T
Hirata, K
Shinohara, K
Katoh, S
Zhao, SJ
Tamaki, N
Noguchi, Y
Noguchi, S
机构
[1] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan
[2] Noguchi Tyroid Clin & Hosp Fdn, Beppu, Oita, Japan
关键词
salivary gland; radioiodine therapy; thyroid cancer; amifostine;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Salivary gland dysfunction is one of the common side effects of high-dose radioiodine therapy for thyroid cancer. The purpose of this study was to determine whether an early start of sucking lemon candy decreases salivary gland injury after radioiodine therapy. Methods: The incidence of the side effects of radioiodine therapy on the salivary glands was prospectively and longitudinally investigated in 2 groups of patients with postsurgical differentiated thyroid cancer with varying regimens for sucking lemon candy. From August 1999 to October 2000, 116 consecutive patients were asked to suck 1 or 2 lemon candies every 2-3 h in the daytime of the first 5 d after radioiodine therapy (group A). Lemon candy sucking was started within 1 h after radioiodine ingestion. From November 2000 to June 2002, 139 consecutive patients (group B) were asked to suck lemon candies in a manner similar to that of group A. In the group B, lemon candies were withheld until 24 h after the ingestion of radioiodine. Patients with salivary gland disorders, diabetes, collagen tissue diseases, or a previous history of radioiodine therapy or external irradiation to the neck were excluded. Thus, 105 patients in group A and 125 patients in group B were available for analysis. There were no statistical differences in the mean age (55.2 y vs. 58.5 y), average levels of serum free thyroxine (L-3,5,3',5'-tetraiodothyronine) (0.40 ng/dL vs. 0.47 ng/dL), and the mean dose of I-131 administered (3.96 GBq vs. 3.87 GBq) between the 2 groups. The onset of salivary side effects was monitored during hospital admission and regular follow-up on the basis of interviews with patients, a visual analog scale, and salivary gland scintigraphy using Tc-99m-pertechnetate. When a patient showed a persistent (>4 mo) dry mouth associated with a nonfunctioning pattern on salivary gland scintigraphy, a diagnosis of xerostomia was established. Results: The incidences of sialoadenitis, hypogeusia or taste loss, and dry mouth with or without repeated sialadenitis in group A versus group B were 63.8% versus 36.8% (P < 0.001), 39.0% versus 25.6% (P < 0.01), and 23.8% versus 11.2% (P < 0.005), respectively. Permanent xerostomia occurred in 15 patients in group A (14.3%) and 7 patients in group B (5.6%) (P < 0.05). In both groups, bilateral involvement of the parotid gland was the most frequently seen and was followed by bilateral involvement of the submandibular gland. Conclusion: An early start of sucking lemon candy may induce a significant increase in salivary gland damage. Lemon candy should not be given until 24 h after radioiodine therapy.
引用
下载
收藏
页码:261 / 266
页数:6
相关论文
共 50 条
  • [11] Submandibular glands dysfunction on salivary gland scintigraphy after radioiodine therapy in thyroid cancer patients
    Jang, Sujin
    Lee, Won Woo
    Kim, Sang Eun
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [12] Effects of pilocarpine on salivary gland function after postoperative radioiodine therapy for differntiated thyroid cancer
    Lim, Jae-Yol
    Choi, Jeong-Seok
    Kim, Young-Mo
    ORAL ONCOLOGY, 2013, 49 : S141 - S141
  • [13] Salivary gland scintigraphy to detect chronic salivary gland damages after high dose radioiodine therapy for thyroid cancer: Correlation with sialography
    Nakada, Kunihiro
    Satou, Yasusi
    Sakurai, Masayuki
    Ohmori, Keiichi
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [14] Salivary gland scintigraphy after radioiodine therapy
    Malpani, BL
    Samuel, AM
    Jaiswar, RK
    NUCLEAR MEDICINE COMMUNICATIONS, 1998, 19 (02) : 183 - 184
  • [15] Salivary gland scintigraphy after radioiodine therapy: A reply
    Bohuslavizki, KH
    Brenner, W
    NUCLEAR MEDICINE COMMUNICATIONS, 1998, 19 (02) : 184 - 184
  • [16] Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment
    Caglar, M
    Tuncel, M
    Alpar, R
    CLINICAL NUCLEAR MEDICINE, 2002, 27 (11) : 767 - 771
  • [17] Clinical Studies of Nonpharmacological Methods to Minimize Salivary Gland Damage after Radioiodine Therapy of Differentiated Thyroid Carcinoma: Systematic Review
    Christou, Andri
    Papastavrou, Evridiki
    Merkouris, Anastasios
    Frangos, Savvas
    Tamana, Panayiota
    Charalambous, Andreas
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016
  • [18] Ultrasonographic Features of Salivary Glands after Radioiodine Therapy in Patients with Thyroid Cancer
    Tsur, Nir
    Avishai, Gal
    Alkan, Uri
    Hod, Roy
    Shpitzer, Thomas
    Bitton, Eden
    Gilat, Hanna
    LARYNGOSCOPE, 2023, 133 (05): : 1271 - 1275
  • [19] Does the Use of Amifostine for Salivary Gland Protection Reduce the Rate of Thyroid Remnant Ablation in Patients with Differentiated Thyroid Cancer Receiving Radioiodine Therapy?
    Haindl, W.
    Ting, A. C. C.
    Rossleigh, M. A.
    Som, S. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S122 - S122
  • [20] Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer
    Bohuslavizki, KH
    Klutmann, S
    Bleckmann, C
    Brenner, W
    Lassmann, S
    Mester, J
    Henze, E
    Clausen, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 (02) : 57 - 61